loader from loading.io

Uncertainties Regarding Cerebral Palsy Diagnosis - Part 1

Neurology Minute

Release Date: 12/05/2024

Prodromal Phase of Migraine - Part 1 show art Prodromal Phase of Migraine - Part 1

Neurology Minute

In part one of this two-part series, Dr. Bradley Ong discusses the prodrome phase of migraine and how it represents the earliest stage of the attack.  Show citation:  Lipton RB, Stokes J, Evans CJ, et al. Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing. Headache. 2025;65(8):1355-1368. doi: 

info_outline
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 2 show art Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 2

Neurology Minute

In part two of this series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss gender disparities in the treatment of multiple sclerosis.  Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi: 

info_outline
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 1 show art Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis - Part 1

Neurology Minute

In part one of this two-part series, Dr. Stacey Clardy and Dr. Sandra Vukusic discuss what disease-modifying therapies can be safely continued and strategically timed when pregnancy is anticipated.  Show citation: Gavoille A, Leray E, Marignier R, et al. Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis. Neurology. 105(4) e213907. doi: 

info_outline
Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies show art Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies

Neurology Minute

Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms.  Show citation:  McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi: 

info_outline
Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies show art Neurotoxicity Imaging in Children and Young Adults After CAR T-Cell Therapy for B-Cell Malignancies

Neurology Minute

Dr. Alison Christy and Dr. Jennifer L. McGuire discuss neuroimaging findings linked to ICANS, exploring whether specific imaging patterns correlate with distinct neurologic symptoms.  Show citation:  McGuire JL, Pinto S, Erdogan EN, et al. Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell Malignancies. Neurology. 2025;105(7):e214086. doi: 

info_outline
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 3 show art Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 3

Neurology Minute

In the final episode of this three-part series, Dr. Jeff Lambe addresses practical considerations surrounding the inclusion of the optic nerve as a topography for demonstrating dissemination in space.  Show citation:  Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi: 

info_outline
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 2 show art Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 2

Neurology Minute

In part two of this three-part series, Dr. Jeff Lambe outlines how the optic nerve is being incorporated as one of five topographies used to demonstrate dissemination in space. Show citation:  Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:

info_outline
Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 1  show art Optic Nerve Inclusion in the 2024 McDonald Criteria Revisions – Part 1

Neurology Minute

In part one of this three-part series, Dr. Jeff Lambe discusses the rationale for including the optic nerve in the 2024 revisions to the McDonald criteria.  Show citation:  Montalban X, Lebrun-Frénay C, Oh J, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24(10):850-865. doi:

info_outline
Persistent Postictal Central Apnea in Focal Seizures show art Persistent Postictal Central Apnea in Focal Seizures

Neurology Minute

Dr. Katie Krulisky and Dr. Stefano Meletti discuss the incidence and characteristics of postictal central apnea in focal seizures.   Show citation: Meletti S, Burani M, Ballerini A, et al. Persistent Postictal Central Apnea in Focal Seizures: Incidence, Features, and Imaging Findings. Neurology. 2025;105(4):e213856. doi:  

info_outline
Association Between Consumption of Artificial Sweeteners With Cognitive Decline show art Association Between Consumption of Artificial Sweeteners With Cognitive Decline

Neurology Minute

Dr. Greg Cooper and Dr. Claudia Suemoto discuss the association between consumption of low- and no-calorie sweeteners and cognitive decline.  Show citations:  Gonçalves NG, Martinez-Steele E, Lotufo PA, et al. Association Between Consumption of Low- and No-Calorie Artificial Sweeteners and Cognitive Decline: An 8-Year Prospective Study. Neurology. 2025;105(7):e214023. doi:

info_outline
 
More Episodes

In the first part of this two-part series, Dr. Stacey Clardy and Dr. Bhooma R. Aravamuthan discuss the current definition of cerebral palsy and the appropriate diagnostic labeling in clinical practice.

Show reference:

https://www.neurology.org/doi/10.1212/CPJ.0000000000200353